Skip to main content
OpenTrials
Completed

NCT Number: NCT00497419

Reperfusion Time in ST Segment Elevation Myocardial Infarction (STEMI)

Reperfusion delay in STEMI has been shown to be excessive in our community. In order to improve delay a fast track (direct transfer in catheterization laboratory) has been implemented. The present study aims at evaluating the benefits of this procedure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geneva University Hospital, Emergency Service

Geneva, Canton of Geneva, 1211, Switzerland

About this study

Reperfusion delay in STEMI has been shown to be excessive in our community. Admission in emergency room and waiting for transfer to catheterization laboratory seems to be the principal source of delay. In order to improve delays a fast track (direct transfer in catheterization laboratory) has been implemented for patients being diagnosed with STEMI by emergency physician out of hospital. The present study aims at evaluating the benefits of this procedure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of STEMI

Exclusion criteria

  • On site resuscitated patients

Treatment and study plan

Fast Track

Procedure

Primary outcomes

  1. Door to balloon time

    Time frame: one year

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Registry information

Official study title

Evaluation of a Fast Track for Patients With STEMI

Important dates

Study start
2007
Primary completion
2007
Study completion
2007
First posted
Jul 6, 2007
Registry last updated
Aug 20, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.